Jagsonpal Pharmaceuticals P/B Ratio
Jagsonpal Pharmaceuticals P/B ratio. Jagsonpal Pharmaceuticals (JAGSNPHARM) P/B ratio is 5.7 (High), book value per share ₹212.31 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. View Jagsonpal Pharmaceuticals 52-week for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
JAGSNPHARM P/B Ratio — Valuation Insights & Book Value Analysis
Jagsonpal Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 5.7 (High). Analyse JAGSNPHARM institutional holdings to track promoter, FII and institutional holdings.
- Stock appears overvalued with PB of 5.7, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 335.1% above historical average
- Trading at premium to sector average PB of 0.01
Jagsonpal Pharmaceuticals P/B Ratio Historical Trend
JAGSNPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Jagsonpal Pharmaceuticals stock price NSE.
JAGSNPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
Jagsonpal Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.08 | ₹212.31 | ₹229.47 | ₹276 | Moderate |
| 2025 | 1.04 | ₹184.62 | ₹192.61 | ₹240 | Moderate |
| 2024 | 1.7 | ₹143.85 | ₹244.35 | ₹187 | Moderate |
| 2023 | 1.27 | ₹122.31 | ₹155.55 | ₹159 | Moderate |
| 2022 | 1.46 | ₹102.31 | ₹149.10 | ₹133 | Moderate |
JAGSNPHARM vs Healthcare Peers — P/B Ratio Comparison
Jagsonpal Pharmaceuticals P/B 5.7 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |